By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Max-Dohrn-Strasse 8-10

Berlin    10589  Germany
Phone: 49-30-726247-0 Fax: 49-30-726247-225



Drug Discovery

Company News
NOXXON Pharma AG Demonstrates Synergies Between NOX-A12 And Therapies Working Through T Cells Or NK Cells 10/10/2016 12:17:19 PM
Five Biotechs You Should Know In Berlin 3/11/2016 8:01:57 AM
NOXXON Pharma AG Hosts Key Opinion Leader Symposium 1/20/2016 10:15:12 AM
NOXXON Pharma AG Appoints Aram Mangasarian As CEO 7/14/2015 9:16:46 AM
First Data From NOXXON Pharma AG’s NOX-H94 (Lexaptepid Pegol) Clinical Trial In ESA-Hyporesponsive Dialysis Patients Reported At ERA-EDTA Conference 5/29/2015 9:03:19 AM
NOXXON Pharma AG Release: Nature Communications Publications On The First X-Ray Crystal Structures Of Spiegelmers Bound To Protein Targets 4/23/2015 9:43:02 AM
New Addition To NOXXON Pharma AG Supervisory Board Brings Significant U.S. Public Market Expertise 12/10/2014 8:55:20 AM
NOXXON Pharma AG Release: Phase IIa Results For Spiegelmer Olaptesed Pegol (NOX-A12) In MM And CLL At 2014 American Society of Hematology Conference 12/5/2014 1:31:25 PM
NOXXON Pharma AG Spiegelmer® Receives FDA Orphan Drug 9/23/2014 8:58:58 AM
NOXXON Pharma AG Expands Management Team By Appointing Don Munoz As Chief Financial Officer 9/18/2014 9:29:20 AM